Skip to Main content Skip to Navigation
Journal articles

Immunotherapy of HPV-associated head and neck cancer: critical parameters

Abstract : Various arguments support the development of a vaccine targeting human papillomavirus (HPV) for the treatment of HPV-associated head and neck cancer. However, the mucosal localization of this tumor, the HPV-driven downregulation of MHC Class I molecules and various other immunosuppressive mechanisms must be carefully considered to improve the clinical efficacy of such an immunotherapeutic strategy.
Document type :
Journal articles
Complete list of metadata

https://halshs.archives-ouvertes.fr/halshs-01457167
Contributor : Gwénaëlle Lo Bue Connect in order to contact the contributor
Submitted on : Monday, February 6, 2017 - 12:09:15 PM
Last modification on : Sunday, June 26, 2022 - 12:06:39 PM

Links full text

Identifiers

Citation

Mevyn Nizard, Federico Sandoval, Cécile Badoual, Hélène Péré, Magali Terme, et al.. Immunotherapy of HPV-associated head and neck cancer: critical parameters . OncoImmunology, Taylor & Francis, 2013, 2 (6), pp.e24534. ⟨10.4161/onci.24534⟩. ⟨halshs-01457167⟩

Share

Metrics

Record views

113